Overview

Evaluating the Abuse Potential of NEURONTIN® When Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy Non-drug Dependent, Recreational Opioid Users

Status:
Completed

Trial end date:
2021-12-31

Target enrollment:

Participant gender:

Summary

This will be a randomized, double-blind, double-dummy, placebo- and active-controlled, 6 treatment, 6-period crossover single-dose, Williams square design study in healthy male and/or female adult, non-drug-dependent recreational opioid users.

Phase:

Phase 4

Details

Lead Sponsor:

Viatris Specialty LLC

Treatments:

Gabapentin
Oxycodone